In vitro platforms for tissue engineering: Implications for basic research and clinical translation

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 8, 2011, Pages

  Rouwkema, Jeroen ^a   Gibbs, Susan ^b   Lutolf, Matthias P ^c   Martin, Ivan ^d   Vunjak Novakovic, Gordana ^e   Malda, Jos ^f  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EPFL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Columbia University ^*  (United States)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bioreactor; In vitro model; Mass transfer; Microfluidics; Physical stimulation; Stem cells

Indexed keywords

BIOREACTORS; CELL ENGINEERING; CLINICAL RESEARCH; DIAGNOSIS; HISTOLOGY; MASS TRANSFER; TISSUE; TISSUE ENGINEERING;

BIOREACTOR; CLINICAL TRANSLATION; ENGINEERED TISSUES; ENGINEERING IMPLICATIONS; IN-VITRO; IN-VITRO MODELS; PHYSICAL STIMULATIONS; REGENERATIVE MEDICINE; STEM-CELL; TISSUES ENGINEERINGS;

STEM CELLS;

ARTICLE; BIOCHEMISTRY; BIOPHYSICS; BIOREACTOR; CYTOTOXICITY; FREE TISSUE GRAFT; LANGERHANS CELL; MELANOCYTE; NETHERLANDS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE ENGINEERING;

EID: 79960556762     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.414     Document Type: Article

References (28)

1. Burdick JA, Vunjak-Novakovic G. 2009; Engineered microenvironments for controlled stem cell differentiation. Tissue Eng A 15(2): 205-219.
2. Centis V, Vermette P. 2009; Enhancing oxygen solubility using hemoglobin- and perfluorocarbon-based carriers. Front Biosci 14: 665-688.
3. Discher DE, Mooney DJ, Zandstra PW, et al. 2009; Growth factors, matrices, and forces combine and control stem cells. Science 324(5935): 1673-1677.
4. Du Y, Lo E, Ali S, et al. 2008; Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci USA 105(28): 9522-9527.
5. Freed LE, Guilak F, Guo XE, et al. 2006; Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng 12(12): 3285-3305.
6. Gibbs S. 2009; In vitro irritation models and immune reactions. Skin Pharmacol Physiol 22(2): 103-113.
7. Grayson WL, Frohlich M, Yeager K, et al. 2010; Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci USA 107(8): 3299-3304.
8. Gupta K, Kim DH, Ellison D, et al. 2010; Lab-on-a-chip devices as an emerging platform for stem cell biology. Lab Chip 10(16): 2019-2031.
9. Khetani SR, Bhatia SN. 2006; Engineering tissues for in vitro applications. Curr Opin Biotechnol 17(5): 524-531.
10. Leeuwenburgh SC, Jansen JA, Malda J, et al. 2008; Trends in biomaterials research: an analysis of the scientific programme of the World Biomaterials Congress 2008. Biomaterials 29(21): 3047-3052.
11. Lutolf MP, Blau HM. 2009; Artificial stem cell niches. Adv Mater 21(32-33): 3255-3268.
12. Malda J, Woodfield TB, van der Vloodt F, et al. 2004; The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Biomaterials 25(26): 5773-5780.
13. Martin I, Riboldi SA, Jakob M, et al. 2010; SnapShot: Bioreactors systems in tissue engineering (TE) and regenerative medicine (RM). Biomaterials 31(11): 3114-3115.
14. Martin I, Smith T, Wendt D. 2009; Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends Biotechnol 27(9): 495-502.
15. Martin I, Wendt D, Heberer M. 2004; The role of bioreactors in tissue engineering. Trends Biotechnol 22(2): 80-86.
16. Martin Y, Vermette P. 2005; Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 26(35): 7481-7503.
17. McGuigan AP, Sefton MV. 2006; Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci USA 103(31): 11461-11466.
18. Oh SH, Ward CL, Atala A, et al. 2009; Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials 30(5): 757-762.
19. Radisic M, Marsano A, Maidhof R, et al. 2008; Cardiac tissue engineering using perfusion bioreactor systems. Nat Protocols 3(4): 719-738.
20. Radisic M, Park H, Chen F, et al. 2006; Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 12(8): 2077-2091.
21. Rehfeldt F, Engler AJ, Eckhardt A, et al. 2007; Cell responses to the mechanochemical microenvironment-implications for regenerative medicine and drug delivery. Adv Drug Deliv Rev 59(13): 1329-1339.
22. Reilly GC, Engler AJ. 2010; Intrinsic extracellular matrix properties regulate stem cell differentiation. J Biomech 43(1): 55-62.
23. Rivron NC, Rouwkema J, Truckenmuller R, et al. 2009; Tissue assembly and organization: developmental mechanisms in microfabricated tissues. Biomaterials 30(28): 4851-4858.
24. Rouwkema J, Koopman BFJM, van Blitterswijk CA, et al. 2009; Supply of nutrients to cells in engineered tissues. Biotechnol Genet Eng Rev 26: 175-190.
25. Sung JH, Shuler ML. 2010; In vitro microscale systems for systematic drug toxicity study. Bioprocess Biosyst Eng 33(1): 5-19.
26. Tandon N, Cimetta E, Bhumiratana S, et al. 2010; Bioreactors for tissue engineering. In Biomaterials Science: An Introduction to Materials in Medicine, 3rd edn. Elsevier: Amsterdam.
27. Wendt D, Riboldi SA, Cioffi M, et al. 2009; Bioreactors in tissue engineering: scientific challenges and clinical perspectives. Adv Biochem Eng Biotechnol 112: 1-27.
28. Yamanaka S, Blau HM. 2010; Nuclear reprogramming to a pluripotent state by three approaches. Nature 465(7299): 704-712.